Chlebowski et al. [30, 31] had suggested that insulin or IGF may be important in the ER- breast cancer subset, and the evidence has limited and more studies are needed to eliminate the influence of insulin on ER- breast cancer. This evidence concerns the gene INS and breast cancer.